Kevin L. Salyers

1.2k total citations
21 papers, 517 citations indexed

About

Kevin L. Salyers is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kevin L. Salyers has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Kevin L. Salyers's work include Pharmacogenetics and Drug Metabolism (3 papers), Bone health and treatments (2 papers) and Melanoma and MAPK Pathways (2 papers). Kevin L. Salyers is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Bone health and treatments (2 papers) and Melanoma and MAPK Pathways (2 papers). Kevin L. Salyers collaborates with scholars based in United States, United Kingdom and Canada. Kevin L. Salyers's co-authors include Shrenik M. Nanavati, Sudarsanan Varaprath, I.G. Sipes, Michael R. Zile, Patricia B. Hoyer, Kathleen P. Plotzke, Jodi A. Flaws, William F. Huffman, Leonard M. Azzarano and Keith W. Ward and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kevin L. Salyers

21 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin L. Salyers United States 15 176 97 91 64 61 21 517
Hideharu Ikebuchi Japan 16 207 1.2× 60 0.6× 85 0.9× 41 0.6× 90 1.5× 52 635
Robert W. Tuman United States 14 300 1.7× 90 0.9× 73 0.8× 104 1.6× 25 0.4× 27 588
Iwao Nakatsuka Japan 17 321 1.8× 113 1.2× 174 1.9× 100 1.6× 56 0.9× 102 961
Junko Momma Japan 11 109 0.6× 61 0.6× 65 0.7× 38 0.6× 46 0.8× 36 374
Catherine S. Murphy United States 8 342 1.9× 213 2.2× 72 0.8× 39 0.6× 45 0.7× 9 856
Ann S. Heiman United States 14 214 1.2× 42 0.4× 41 0.5× 72 1.1× 145 2.4× 40 549
Aniruddha Sengupta United States 16 317 1.8× 81 0.8× 160 1.8× 29 0.5× 33 0.5× 30 947
Shunji Ishiwata Japan 17 460 2.6× 119 1.2× 56 0.6× 15 0.2× 49 0.8× 43 715
Mary G. McMenamin United States 12 345 2.0× 195 2.0× 35 0.4× 52 0.8× 60 1.0× 17 709
Zheng-Zheng Shi United States 19 637 3.6× 90 0.9× 29 0.3× 41 0.6× 87 1.4× 26 984

Countries citing papers authored by Kevin L. Salyers

Since Specialization
Citations

This map shows the geographic impact of Kevin L. Salyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin L. Salyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin L. Salyers more than expected).

Fields of papers citing papers by Kevin L. Salyers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin L. Salyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin L. Salyers. The network helps show where Kevin L. Salyers may publish in the future.

Co-authorship network of co-authors of Kevin L. Salyers

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin L. Salyers. A scholar is included among the top collaborators of Kevin L. Salyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin L. Salyers. Kevin L. Salyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Everds, Nancy, Nianyu Li, Keith Bailey, et al.. (2013). Unexpected Thrombocytopenia and Anemia in Cynomolgus Monkeys Induced by a Therapeutic Human Monoclonal Antibody. Toxicologic Pathology. 41(7). 951–969. 15 indexed citations
3.
Bourbeau, Matthew P., Aaron Siegmund, John G. Allen, et al.. (2013). Piperazine Oxadiazole Inhibitors of Acetyl-CoA Carboxylase. Journal of Medicinal Chemistry. 56(24). 10132–10141. 16 indexed citations
4.
Wong, Philip, et al.. (2011). Application of automated serial blood sampling and dried blood spot technique with liquid chromatography–tandem mass spectrometry for pharmacokinetic studies in mice. Journal of Pharmaceutical and Biomedical Analysis. 56(3). 604–608. 28 indexed citations
5.
Beck, Hilary P., Brian M. Fox, John G. Allen, et al.. (2010). Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2752–2755. 29 indexed citations
6.
Jin, Jian, Ming An, Anthony Sapienza, et al.. (2008). Urotensin-II receptor antagonists: Synthesis and SAR of N-cyclic azaalkyl benzamides. Bioorganic & Medicinal Chemistry Letters. 18(14). 3950–3954. 14 indexed citations
7.
Miranda, Les P., Jerry Ryan Holder, Licheng Shi, et al.. (2008). Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor. Journal of Medicinal Chemistry. 51(24). 7889–7897. 28 indexed citations
8.
Palovich, Michael R., Katherine L. Widdowson, Miriam Burman, et al.. (2006). Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1713–1717. 32 indexed citations
9.
Ward, Katie, Joel W. Proksch, Kevin L. Salyers, et al.. (2002). SB-242235, a selective inhibitor of p38 mitogenactivated protein kinase. I: Preclinical pharmacokinetics. Xenobiotica. 32(3). 221–233. 11 indexed citations
10.
Ward, Keith W., Joel W. Proksch, Leonard M. Azzarano, et al.. (2001). SB-239063, a Potent and Selective Inhibitor of P38 Map Kinase: Preclinical Pharmacokinetics and Species-Specific Reversible Isomerization. Pharmaceutical Research. 18(9). 1336–1344. 14 indexed citations
11.
Lark, Michael W., George B. Stroup, Robert A. Dodds, et al.. (2001). Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovariectomized Rat. Journal of Bone and Mineral Research. 16(2). 319–327. 44 indexed citations
12.
Lark, Michael W., George B. Stroup, Shing Mei Hwang, et al.. (1999). Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis. Journal of Pharmacology and Experimental Therapeutics. 291(2). 612–617. 37 indexed citations
13.
Varaprath, Sudarsanan, et al.. (1999). Identification of Metabolites of Octamethylcyclotetrasiloxane (D4) in Rat Urine. Drug Metabolism and Disposition. 27(11). 1267–1273. 48 indexed citations
14.
Ward, Keith W., Leonard M. Azzarano, William E. Bondinell, et al.. (1999). Preclinical Pharmacokinetics and Interspecies Scaling of a Novel Vitronectin Receptor Antagonist. Drug Metabolism and Disposition. 27(11). 1232–1241. 33 indexed citations
15.
Varaprath, Sudarsanan, Kevin L. Salyers, Kathleen P. Plotzke, & Shrenik M. Nanavati. (1998). Extraction of Octamethylcyclotetrasiloxane and Its Metabolites from Biological Matrices. Analytical Biochemistry. 256(1). 14–22. 40 indexed citations
16.
Salyers, Kevin L.. (1995). Disposition and metabolism of 4-vinyl-1-cyclohexene diepoxide in female Fischer 344 rats and B6C3F(1) mice. UA Campus Repository (The University of Arizona). 2 indexed citations
17.
Salyers, Kevin L., et al.. (1994). In vitrometabolism of theophylline by rat and human liver tissue. Xenobiotica. 24(5). 389–399. 18 indexed citations
18.
Flaws, Jodi A., Kevin L. Salyers, I.G. Sipes, & Patricia B. Hoyer. (1994). Reduced Ability of Rat Preantral Ovarian Follicles to Metabolize 4-Vinyl-1-cyclohexene Diepoxide in Vitro. Toxicology and Applied Pharmacology. 126(2). 286–294. 39 indexed citations
19.
Salyers, Kevin L., Malford E. Cullum, & Maija H. Zile. (1993). Glucuronidation of all-trans-retinoic acid in liposomal membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1152(2). 328–334. 11 indexed citations
20.
Salyers, Kevin L., et al.. (1989). Effect of tetrachlorodibenzo-p-dioxin (TCDD) on the glucuronidation of retinoic acid in the rat. Biochimica et Biophysica Acta (BBA) - General Subjects. 993(1). 1–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideharu Ikebuchi Breakdown of academic impact, for papers by Robert W. Tuman Breakdown of academic impact, for papers by Iwao Nakatsuka Breakdown of academic impact, for papers by Junko Momma Breakdown of academic impact, for papers by Catherine S. Murphy Breakdown of academic impact, for papers by Ann S. Heiman Breakdown of academic impact, for papers by Aniruddha Sengupta Breakdown of academic impact, for papers by Shunji Ishiwata Breakdown of academic impact, for papers by Mary G. McMenamin Breakdown of academic impact, for papers by Zheng-Zheng Shi
Rankless by CCL
2026